TAIPEI: The chief of the Executive Yuan, Wu Den-yi, said yesterday that clinical trials on humans show that a locally produced swine flu vaccine is comparable to the imported one in terms of safety and efficacy.

Wu made the remarks in an effort to enhance public confidence in the Adimmune Corp-produced vaccine for swine flu, officially known as influenza A(H1N1).

Speaking at a weekly "cabinet" meeting during which he was briefed on the current state of the nationwide H1N1 immunization campaign, Wu said epidemic control personnel should step up efforts to publicize the vaccine to reassure the public that the locally produced vaccine has proved to be as effective as the imported one in a series of clinical trials.

"More publicity efforts are needed to dispel public misgivings, " Wu said, adding that he hopes more parents will be encouraged to have their children get swine flu shots.

Moreover, health care personnel should step up monitoring of any possible vaccine-induced adverse effects and take measures to ward off public panic, Wu said.

As drug-resistant strains of the H1N1 virus have been reported abroad, Wu said epidemic control staff should heighten their alert status and keep abreast of the latest relevant information reported by the World Health Organization.

"Health care agencies at all levels should get prepared for worst-case scenarios," Wu stressed.

With the December 5 three-in-one elections for local government and council posts approaching, Wu said the ad hoc Central Epidemic Control Center (CECC) should closely monitor public reaction to various epidemic prevention measures, including class suspension, vaccination and polling station arrangements during the election.

"The CECC should factor in general public demand and exercise proper flexibility in epidemic control measures to avert any possible public complaints or grievances," Wu said.

According to a Department of Health (DOH) report, 206 countries around the world have reported H1N1 cases to the World Health Organization, with at least 6,260 fatalities, since the swine flu outbreak began.

As of Wednesday, 602 H1N1 patients had been hospitalized for H1N1 infections in Taiwan, 29 of whom had died while most others had been discharged after recovery.

The present nationwide immunization drive was launched on November 1, with vaccines supplied by multinational pharmaceutical plant Novartis. On November 16, the locally produced vaccine came into use in inoculations of school children.

According to the DOH's immunization program, fourth graders and older children need only one H1N1 shot, while younger children should receive two.

China Daily/CNA

(HK Edition 11/20/2009 page2)